WATCHMAN* Device: Investigational or Standard of Care?

This 30-min webinar examined the medical necessity of WATCHMAN as an alternative to oral anticoagulants for reducing stroke risk in patients with non-valvular atrial fibrillation.

Download webinar presentation, position paper, and questions & answers.

AllMed’s Medical Director, Dr. David Spiro, led a 30-min interactive discussion with Dr. Joseph Guzzo, a board-certified cardiologist, on the medical necessity of WATCHMAN as an alternative to oral anticoagulants for reducing stroke risk in patients with non-valvular atrial fibrillation. This webinar used a real patient case to examine the complexities that arise to help payers and providers make informed, evidence-based decisions.

* Trademarks™ or register® trademarks are properties of their respective owners. Use of them does not imply any affiliation with or endorsement by them.